Vanguard Group’s Syneron Medical Ltd ELOS Stock Holding History

Vanguard Group’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-158,000	Closed	-$1.73M	–	4121
2017 Q2	$1.73M	Buy	+158,000	New	+$1.73M	﹤0.01%	3422

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Vanguard Group's ELOS Position: Q3 2017 in Review

Vanguard Group sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 158,000 shares — an estimated $1.73M sold.

Vanguard Group first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $1.73M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

Vanguard Group reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
Vanguard Group sold 158,000 Syneron Medical Ltd shares in Q3 2017, an estimated $1.73M.
Vanguard Group first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
Vanguard Group's Syneron Medical Ltd position peaked at $1.73M in Q2 2017.
4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Vanguard Group's 13F filing for Q3 2017, filed 14 Nov 2017.